Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Profile Name | BARD1 V85M |
| Gene Variant Detail | |
| Relevant Treatment Approaches | Olaparib |
| Molecular Profile | Indication/Tumor Type | Response Type | Relevant Treatment Approaches | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|---|---|---|---|---|---|---|---|
| BARD1 V85M | breast cancer | sensitive | Cisplatin | Preclinical - Cell culture | Actionable | In a preclinical study, a breast cancer cell line expressing BARD1 V85M was sensitive to Platinol (cisplatin) in culture, demonstrating decreased colony formation (PMID: 39387837). | 39387837 | |
| BARD1 V85M | breast cancer | sensitive | Olaparib | Olaparib | Preclinical - Cell culture | Actionable | In a preclinical study, a breast cancer cell line expressing BARD1 V85M was sensitive to Lynparza (olaparib) in culture, demonstrating decreased colony formation (PMID: 39387837). | 39387837 |
| BARD1 V85M | breast cancer | sensitive | Cisplatin + Olaparib | Preclinical - Cell culture | Actionable | In a preclinical study, a breast cancer cell line expressing BARD1 V85M was sensitive to treatment with the combination of Platinol (cisplatin) and Lynparza (olaparib) in culture, demonstrating decreased colony formation (PMID: 39387837). | 39387837 | |
| BARD1 V85M | ovarian cancer | sensitive | Cisplatin | Preclinical - Cell culture | Actionable | In a preclinical study, an ovarian cancer cell line expressing BARD1 V85M was sensitive to Platinol (cisplatin) in culture, demonstrating decreased colony formation (PMID: 39387837). | 39387837 | |
| BARD1 V85M | ovarian cancer | sensitive | Olaparib | Olaparib | Preclinical - Cell culture | Actionable | In a preclinical study, an ovarian cancer cell line expressing BARD1 V85M was sensitive to Lynparza (olaparib) in culture, demonstrating decreased colony formation (PMID: 39387837). | 39387837 |
| BARD1 V85M | ovarian cancer | sensitive | Cisplatin + Olaparib | Preclinical - Cell culture | Actionable | In a preclinical study, an ovarian cancer cell line expressing BARD1 V85M was sensitive to treatment with the combination of Platinol (cisplatin) and Lynparza (olaparib) in culture, demonstrating decreased colony formation (PMID: 39387837). | 39387837 |